v3.25.1

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Selling, general and administrative	$ 100,244	$ 233,109	$ 642,959	$ 689,111
Research and development expense	12,096	105,837	34,748	461,969
Depreciation and amortization expense	0	13,377	0	40,531
Total operating expense	112,341	352,323	677,708	1,191,611
Loss from operations	(112,341)	(352,323)	(677,708)	(1,191,611)
Other income (expense)
Interest expense	(52,402)	(36,437)	(200,748)	(77,499)
Loss on settlement of obligations	0	0	0	(40,000)
Gain (loss) on derivative liability	128,545	0	61,664	0
Total other income (expense)	76,143	(36,437)	(139,084)	(117,499)
Net income (loss) income	(36,197)	(388,760)	(816,792)	(1,309,110)
Net income (loss) attributable to common stockholders	$ (36,197)	$ (388,760)	$ (816,792)	$ (1,309,110)
Basic income (loss) income per share attributable to common stockholders	$ (0)	$ (0)	$ (0.01)	$ (0.02)
Diluted income (loss) earnings per share attributable to common stockholders	$ (0)	$ (0)	$ (0.01)	$ (0.02)
Basic weighted average number of shares outstanding	83,770,337	83,239,115	84,353,693	83,461,806
Diluted weighted average number of shares outstanding	83,770,337	83,239,115	84,353,693	83,461,806

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Biostax Corp. 10-Q